Related Experiment Video
Updated: Aug 5, 2026

Quantitative Immunofluorescence to Measure Global Localized Translation
Published on: August 22, 2017
Approaches for Studying Context Specificity of Translation Inhibitor Action
Ekaterina S Komarova1,2, Arina A Nikandrova1,3,4, Olga A Dontsova1,2,3,5
1A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Abstract:
The sequence of messenger RNA (mRNA) not only determines the protein sequence synthesized by a ribosome but also defines the efficiency of this process. Many antibiotics lethal to bacteria inhibit various stages of translation by targeting ribosomal functional centers. Some antibiotics exhibit specificity not only for particular stages of the ribosomal working cycle but also for specific patterns within mRNA sequences. This review covers a broad range of approaches-including in vivo and in vitro methods, low- and high-throughput techniques such as reporter constructs, characterization of inhibitors of protein synthesis (ChIPS), toeprinting, cryogenic electron microscopy (cryo-EM), protein labeling, and those integrated with next-generation sequencing (NGS) like ribosome profiling with following NGS (Ribo-seq), inverse toeprinting coupled with NGS (iTP-seq), high-throughput toeprinting and NGS (Toe-seq), and ribosome display-used to study the sequence specificity of translation inhibitors, a rapidly evolving field crucial to molecular biology. It presents various methodologies, discusses their applications, and provides a comparative analysis. The fundamental research value of this review lies in establishing standardized experimental selection guidelines for scientists investigating ribosome stalling mechanisms, thereby minimizing trial-and-error costs. Equally important is its applied relevance. The review highlights its translational value in aiding the screening and mechanistic analysis of sequence-specific small-molecule inhibitors. Moreover, understanding the mechanisms underlying protein biosynthesis inhibition and their dependence on particular mRNA sequences could enable the development of selective agents that precisely suppress the synthesis of certain polypeptides, such as proteins from pathogenic bacteria or cancer-associated proteins.
Insights
This review explores methods for studying how mRNA sequences affect protein synthesis and how antibiotics target translation. It provides guidelines for investigating ribosome stalling and developing sequence-specific inhibitors.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Messenger RNA (mRNA) sequence dictates protein synthesis efficiency and is targeted by antibiotics.
- Antibiotics can exhibit specificity for translation stages and mRNA sequence patterns.
Purpose of the Study:
- To review methodologies for studying sequence-specific translation inhibitors.
- To provide guidelines for investigating ribosome stalling mechanisms.
- To highlight the translational value in developing targeted inhibitors.
Main Methods:
- Covers in vivo and in vitro techniques, including reporter constructs, ChIPS, toeprinting, cryo-EM, and protein labeling.
- Integrates next-generation sequencing (NGS) methods like Ribo-seq, iTP-seq, Toe-seq, and ribosome display.
- Discusses comparative analysis of various experimental approaches.
Main Results:
- Presents a broad range of techniques for studying translation inhibitor sequence specificity.
- Establishes experimental selection guidelines for ribosome stalling research.
- Highlights the role of mRNA sequence in antibiotic efficacy and inhibitor development.
Conclusions:
- Understanding translation inhibition mechanisms and mRNA sequence dependence is crucial for developing selective agents.
- This review aids in screening and mechanistic analysis of sequence-specific small-molecule inhibitors.
- Enables precise suppression of specific polypeptide synthesis, targeting pathogenic or cancer-associated proteins.
Related Concept Videos
Leaky Scanning
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Inhibitors of Viral Protein Synthesis
Enzyme Inhibition
Translational Regulation

